“…According to previous studies, this protein is overexpressed in 12â70% of cervical cancers [7,13,14,15,16,17,18,19,20,21,22]. Overexpression of c-erbB-2 has been associated with more advanced disease stages, and a worse prognosis [13,14,15, 17,19,20,21,22]. However, these observations remain controversial and, hence, definitive conclusions cannot be drawn [7, 16, 18].…”